0001209191-21-065327.txt : 20211117 0001209191-21-065327.hdr.sgml : 20211117 20211117203018 ACCESSION NUMBER: 0001209191-21-065327 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211115 FILED AS OF DATE: 20211117 DATE AS OF CHANGE: 20211117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taylor Ian CENTRAL INDEX KEY: 0001753281 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38672 FILM NUMBER: 211422294 MAIL ADDRESS: STREET 1: C/O ARVINAS, INC., 5 SCIENCE PARK STREET 2: 395 WINCHESTER AVENUE CITY: NEW HAVEN STATE: CT ZIP: 0651 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARVINAS, INC. CENTRAL INDEX KEY: 0001655759 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472566120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 WINCHESTER AVE STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-535-1456 MAIL ADDRESS: STREET 1: 395 WINCHESTER AVE STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 FORMER COMPANY: FORMER CONFORMED NAME: ARVINAS INC. DATE OF NAME CHANGE: 20181001 FORMER COMPANY: FORMER CONFORMED NAME: ARVINAS HOLDING COMPANY, LLC DATE OF NAME CHANGE: 20151015 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-15 0 0001655759 ARVINAS, INC. ARVN 0001753281 Taylor Ian C/O ARVINAS, INC. 5 SCIENCE PARK, 395 WINCHESTER AVE. NEW HAVEN CT 06511 0 1 0 0 Chief Scientific Officer Common Stock 2021-11-15 4 M 0 12206 16.00 A 90851 D Common Stock 2021-11-15 4 M 0 7794 19.36 A 98645 D Common Stock 2021-11-15 4 S 0 6856 83.0673 D 91789 D Common Stock 2021-11-15 4 S 0 6660 84.1429 D 85129 D Common Stock 2021-11-15 4 S 0 6484 84.9545 D 78645 D Stock Option (right to buy) 16.00 2021-11-15 4 M 0 12206 0.00 D 2028-09-25 Common Stock 12206 8943 D Stock Option (right to buy) 19.36 2021-11-15 4 M 0 7794 0.00 D 2029-02-28 Common Stock 7794 57633 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.66 to $83.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.66 to $84.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.66 to $85.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested on March 31, 2019 with the remainder of the shares vesting in equal monthly installments through March 31, 2022. This option award was granted on March 1, 2019. 1/4 of the shares underlying the award vested on March 1, 2020, with the remainder of the shares vesting in equal monthly installments through March 1, 2023. /s/ Matthew Batters, as attorney-in-fact for Ian Taylor 2021-11-17